Drugs / Curcumin C3 complex®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03598309 Comparator | Jun 2019 → May 2025 overdue | lung cancer | H. Lee Moffitt Cancer Center and Research Institute | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Curcumin C3 complex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03598309 ↗ |
| Route | Oral | “4 grams by mouth, twice a day, AM and PM” NCT03598309 ↗ |